(AGS) ageas SA/NV - Ratings and Ratios

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974264930

AGS: Life Insurance, Property Insurance, Casualty Insurance, Reinsurance

Ageas SA/NV, a leading insurance group founded in 1824 and headquartered in Brussels, Belgium, operates across five key segments: Belgium, Europe, Asia, Reinsurance, and General Account. The company specializes in a diverse range of insurance products, including life, property, and casualty insurance, as well as pension products and reinsurance solutions. Its life insurance offerings cover risks associated with individual life and death, while non-life products include accident and health, motor, fire, and other property damage insurance. Ageas serves a broad customer base, from private individuals to small, medium, and large enterprises, primarily through independent brokers and bank channels. The company has a strong presence in 14 countries, with a significant focus on emerging markets in Asia. Ageas has established long-term partnerships with banks and other financial institutions to distribute its insurance products, leveraging its extensive network to deliver tailored solutions to its clients. The company is also committed to sustainability and digital transformation, investing in initiatives that enhance customer experience and operational efficiency. For more information, visit https://www.ageas.com.

Over the next three months, Ageas SA/NV (BR:AGS) is expected to show moderate price movement, influenced by both technical and fundamental factors. Technically, the stock is currently trading near its SMA 20 (53.49) and SMA 50 (53.14), with the SMA 200 (47.64) indicating a longer-term uptrend. The ATR of 1.29 suggests moderate volatility, with potential price fluctuations within a narrow range. On the fundamental side, the companys P/E ratio of 8.49 and forward P/E of 6.25 indicate undervaluation relative to its earnings potential. The P/B ratio of 1.24 and RoE of 13.73% highlight strong book value and profitability. Given these factors, the stock is likely to experience short-term gains, potentially reaching 55.00, while longer-term upside remains supported by its attractive valuation and solid financial performance.

Additional Sources for AGS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AGS Stock Overview

Market Cap in USD 10,642m
Sector Financial Services
Industry Insurance - Diversified
GiC Sub-Industry Multi-line Insurance
IPO / Inception

AGS Stock Ratings

Growth Rating 84.2
Fundamental 12.7
Dividend Rating 68.9
Rel. Strength 12.1
Analysts -
Fair Price Momentum 64.27 EUR
Fair Price DCF 68.31 EUR

AGS Dividends

Dividend Yield 12m 10.36%
Yield on Cost 5y 24.13%
Annual Growth 5y 4.17%
Payout Consistency 84.6%

AGS Growth Ratios

Growth Correlation 3m 59.1%
Growth Correlation 12m 92.2%
Growth Correlation 5y 72.9%
CAGR 5y 19.86%
CAGR/Max DD 5y 0.78
Sharpe Ratio 12m 2.05
Alpha 26.43
Beta 0.378
Volatility 32.35%
Current Volume 264.3k
Average Volume 20d 494.4k
What is the price of AGS stocks?
As of May 01, 2025, the stock is trading at EUR 54.85 with a total of 264,335 shares traded.
Over the past week, the price has changed by +2.81%, over one month by -0.90%, over three months by +10.58% and over the past year by +35.98%.
Is ageas SA/NV a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, ageas SA/NV is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AGS as of May 2025 is 64.27. This means that AGS is currently undervalued and has a potential upside of +17.17% (Margin of Safety).
Is AGS a buy, sell or hold?
ageas SA/NV has no consensus analysts rating.
What are the forecast for AGS stock price target?
According to ValueRays Forecast Model, AGS ageas SA/NV will be worth about 70.4 in May 2026. The stock is currently trading at 54.85. This means that the stock has a potential upside of +28.39%.
Issuer Forecast Upside
Wallstreet Target Price 55.9 2%
Analysts Target Price - -
ValueRay Target Price 70.4 28.4%